BAY 63–2521, an oral soluble guanylate cyclase stimulator, has a favourable safety profile, improves cardiopulmonary haemodynamics and has therapeutic potential in pulmonary hypertension

Ghofrani, Hossein Ardeschir; Weimann, Gerrit; Frey, Reiner; Voswinckel, Robert; Thamm, Melanie; Bölkow, Desire; Weissmann, Norbert; Mück, Wolfgang; Unger, Sigrun; Wensing, Georg; Schermuly, Ralph Theo; Grimminger, Friedrich

doi:10.1186/1471-2210-7-S1-S8

BMC Pharmacology

Article metrics
Last updated: Fri, 19 Apr 2024 4:15:29 Z

BAY 63–2521, an oral soluble guanylate cyclase stimulator, has a favourable safety profile, improves cardiopulmonary haemodynamics and has therapeutic potential in pulmonary hypertension

Access & Citations

2344

Article Accesses
0

Web of Science
6

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.